Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1984 Apr;199(4):461–466. doi: 10.1097/00000658-198404000-00014

Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.

A Miyauchi, T Onishi, S Morimoto, S Takai, F Matsuzuka, K Kuma, M Maeda, Y Kumahara
PMCID: PMC1353366  PMID: 6712322

Abstract

Plasma calcitonin (CT) levels were measured serially in 54 patients surgically treated for medullary thyroid carcinoma. Patients with postoperative basal CT levels higher than 1 ng/ml measured within 1 month after surgery had a higher recurrence rate than those with lower CT levels (p less than 0.002). Patients with postoperative basal CT levels higher than 2 ng/ml had a lower survival rate than those with lower CT levels (p less than 0.01). However, preoperative basal CT levels had no significant correlation with life expectancy or recurrence during the present observation period. Serial measurements in 23 patients with elevated postoperative CT levels showed exponential increases in basal CT levels in 19 patients (p less than 0.05 in nine patients, 0.05 less than p less than 0.1 in four patients) and slight decreases in four (p less than 0.05 in one patient). Doubling time of CT levels calculated from the regression line in each patient showed the highest correlation with 3-year survival, recurrence within 5 years, and time interval between surgery and clinical recurrence of the tumor, allowing quantitative prediction of the prognosis.

Full text

PDF
464

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bussolati G., Monga G. Medullary carcinoma of the thyroid with atypical patterns. Cancer. 1979 Nov;44(5):1769–1777. doi: 10.1002/1097-0142(197911)44:5<1769::aid-cncr2820440534>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  2. COLLINS V. P., LOEFFLER R. K., TIVEY H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med. 1956 Nov;76(5):988–1000. [PubMed] [Google Scholar]
  3. Chong G. C., Beahrs O. H., Sizemore G. W., Woolner L. H. Medullary carcinoma of the thyroid gland. Cancer. 1975 Mar;35(3):695–704. doi: 10.1002/1097-0142(197503)35:3<695::aid-cncr2820350323>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  4. Deftos L. J. Radioimmunoassay for calcitonin in medullary thyroid carcinoma. JAMA. 1974 Jan 28;227(4):403–406. [PubMed] [Google Scholar]
  5. Emmertsen K., Elbrønd O., Nielsen H. E., Mosekilde L., Charles P., Kaae S., Hansen H. H. Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment. Eur J Cancer Clin Oncol. 1982 Jul;18(7):645–650. doi: 10.1016/0277-5379(82)90210-3. [DOI] [PubMed] [Google Scholar]
  6. Hillyard C. J., Cooke T. J., Coombes R. C., Evans I. M., Macintyre I. Normal plasma calcitonin: circadian variation and response to stimuli. Clin Endocrinol (Oxf) 1977 Apr;6(4):291–298. doi: 10.1111/j.1365-2265.1977.tb02014.x. [DOI] [PubMed] [Google Scholar]
  7. Jackson C. E., Tashjian A. H., Jr, Block M. A. Detection of medullary thyroid cancer by calcitonin assay in families. Ann Intern Med. 1973 Jun;78(6):845–852. doi: 10.7326/0003-4819-78-6-845. [DOI] [PubMed] [Google Scholar]
  8. Kakudo K., Miyauchi A., Ogihara T., Takai S. I., Kitamura H., Kosaki G., Kumahara Y. Medullary carcinoma of the thyroid. Giant cell type. Arch Pathol Lab Med. 1978 Sep;102(9):445–447. [PubMed] [Google Scholar]
  9. Kusama S., Spratt J. S., Jr, Donegan W. L., Watson F. R., Cunningham C. The cross rates of growth of human mammary carcinoma. Cancer. 1972 Aug;30(2):594–599. doi: 10.1002/1097-0142(197208)30:2<594::aid-cncr2820300241>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  10. Melvin K. E., Tashjian A. H., Jr, Miller H. H. Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res. 1972;28:399–470. [PubMed] [Google Scholar]
  11. Mendelsohn G., Baylin S. B., Bigner S. H., Wells S. A., Jr, Eggleston J. C. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol. 1980 Aug;4(4):333–341. doi: 10.1097/00000478-198008000-00002. [DOI] [PubMed] [Google Scholar]
  12. Miyauchi A., Morimoto S., Onishi T., Takai S., Okada Y., Himeno S., Kosaki G., Kumahara Y. Meal-related changes in plasma calcitonin levels in patients with medullary thyroid carcinoma. Endocrinol Jpn. 1980 Apr;27(2):153–156. doi: 10.1507/endocrj1954.27.153. [DOI] [PubMed] [Google Scholar]
  13. Normann T., Gautvik K. M., Johannessen J. V., Brennhovd I. O. Medullary carcinoma of the thyroid in Norway. Clinical course and endocrinological aspects. Acta Endocrinol (Copenh) 1976 Sep;83(1):71–85. doi: 10.1530/acta.0.0830071. [DOI] [PubMed] [Google Scholar]
  14. Okada Y., Morimoto S., Onishi T., Tanaka K., Tsuji M., Kumahara Y., Tsushima S., Nakazawa N., Ogawa H., Sakakibara S. Radioimmunoassay of human calcitonin using labeled [Asu1, 7]-human calcitonin analogue. Endocrinol Jpn. 1978 Dec;25(6):617–622. doi: 10.1507/endocrj1954.25.617. [DOI] [PubMed] [Google Scholar]
  15. Philippe E., Le Gal Y. Growth of seventy-eight recurrent mammary cancers. Quantitative study. Cancer. 1968 Mar;21(3):461–467. doi: 10.1002/1097-0142(196803)21:3<461::aid-cncr2820210317>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  16. Stepanas A. V., Samaan N. A., Hill C. S., Jr, Hickey R. C. Medullary thyroid carcinoma: importance of serial serum calcitonin measurement. Cancer. 1979 Mar;43(3):825–837. doi: 10.1002/1097-0142(197903)43:3<825::aid-cncr2820430308>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  17. Tashijan A. H., Jr, Howland B. G., Melvin K. E., Hill C. S., Jr Immunoassay of human calcitonin. N Engl J Med. 1970 Oct 22;283(17):890–895. doi: 10.1056/NEJM197010222831702. [DOI] [PubMed] [Google Scholar]
  18. Trump D. L., Mendelsohn G., Baylin S. B. Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma. N Engl J Med. 1979 Aug 2;301(5):253–255. doi: 10.1056/NEJM197908023010507. [DOI] [PubMed] [Google Scholar]
  19. WELIN S., YOUKER J., SPRATT J. S., Jr THE RATES AND PATTERNS OF GROWTH OF 375 TUMORS OF THE LARGE INTESTINE AND RECTUM OBSERVED SERIALLY BY DOUBLE CONTRAST ENEMA STUDY (MALMOE TECHNIQUE). Am J Roentgenol Radium Ther Nucl Med. 1963 Oct;90:673–687. [PubMed] [Google Scholar]
  20. Wells S. A., Jr, Baylin S. B., Gann D. S., Farrell R. E., Dilley W. G., Preissig S. H., Linehan W. M., Cooper C. W. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg. 1978 Sep;188(3):377–383. doi: 10.1097/00000658-197809000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wells S. A., Jr, Baylin S. B., Leight G. S., Dale J. K., Dilley W. G., Farndon J. R. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg. 1982 May;195(5):595–599. doi: 10.1097/00000658-198205000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wells S. A., Jr, Ontjes D. A., Cooper C. W., Hennessy J. F., Ellis G. J., McPherson H. T., Sabiston D. C., Jr The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II. Ann Surg. 1975 Oct;182(4):362–370. doi: 10.1097/00000658-197510000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wolfe H. J., Melvin K. E., Cervi-Skinner S. J., Saadi A. A., Juliar J. F., Jackson C. E., Tashjian A. H., Jr C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med. 1973 Aug 30;289(9):437–441. doi: 10.1056/NEJM197308302890901. [DOI] [PubMed] [Google Scholar]
  24. Zeman V., Nemec J., Platil A., Zamrazil V., Pohunková D., Neradilová M. Anaplastic transformation of medullary thyroid cancer. Neoplasma. 1978;25(2):249–255. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES